A detailed history of Cordasco Financial Network transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Cordasco Financial Network holds 200 shares of DNA stock, worth $2,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Holding current value
$2,016
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

BUY
$2.2 - $4.2 $440 - $840
200 New
200 $0

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Cordasco Financial Network Portfolio

Follow Cordasco Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordasco Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on Cordasco Financial Network with notifications on news.